ABSTRACT: Mast cells are well known for their involvement in allergic and anaphylactic reactions, but recent findings implicate them in a variety of inflammatory diseases affecting different organs, including the heart, joints, lungs, and skin. In these cases, mast cells appear to be activated by triggers other than aggregation of their IgE receptors (FcRI), such as anaphylatoxins, immunoglobulin-free light chains, superantigens, neuropeptides, and cytokines leading to selective release of mediators without degranulation. These findings could explain inflammatory diseases, such as asthma, atopic dermatitis, coronary inflammation, and inflammatory arthritis, all of which worsen by stress. It is proposed that the pathogenesis of these diseases involve mast cell activation by local release of corticotropin-releasing hormone (CRH) or related peptides. Combination of CRH receptor antagonists and mast cell inhibitors may present novel therapeutic interventions.
Bronchonstriction, pain Nitric oxide (NO) Vasodilation ABBREVIATIONS: TNF-␣: tumor necrosis factor-␣; INF␥ : Interferon-␥ ; MIF: macrophage inflammatory factor; GM-CSF: granulocyte monocyte-colony stimulating factor; b-FGF: fibroblast growth factor; NGF: nerve growth factor; SCF: stem cell factor; VEGF: vascular endothelial growth factor. are present in the skin. 55 Acute stress releases CRH in the skin, 56 inducing a local response. 54 Acute stress also induces redistribution of leukocytes from the systemic circulation to the skin 57 ; it also exacerbates skin delayed hypersensitivity reactions 58 and chronic contact dermatitis in rats, an effect that depends on mast cells and CRH-1 receptors (CRHR-1).
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Computer-induced stress enhanced allergen-specific responses with concomitant increase in plasma SP levels in patients with atopic dermatitis. 60 Similar findings with increased plasma levels of SP, VIP, and NGF, along with a switch to a TH2 cytokine pattern, were reported in patients with atopic dermatitis playing video games. 61 Exercise was also shown to increase the 64 can activate skin mast cells and induce mast-cell-dependent vascular permeability in rodents. CRH also increases vascular permeability in human skin, 65 a process dependent on mast cells. CRH-R2 receptor expression was shown to be upregulated in stress-induced alopecia in humans, 66 CRH-R2 expression was increased in chronic urticaria. 67 Acute restraint stress induces rat skin vascular permeability, 68 an effect inhibited by a CRH receptor antagonist and absent in mast-cell-deficient mice. 63, 64 Proteases released from mast cells could act on plasma albumin to generate histamine-releasing peptides, 69, 70 which would further propagate mast cell activation and inflammation. Proteases could also stimulate protease-activated receptors (PARs), inducing microleakage and widespread inflammation. 71, 72 Many dermatoses, such as atopic dermatitis (AD), chronic urticaria, and psoriasis, are triggered or exacerbated by stress, 73 which also worsens eczema 74 and acne vulgaris. 75 Mast cells are localized close to CRH-positive neurons in the median eminence 76 and express functional CRH receptors. 77 The median eminence is rich in mast cells 78, 79 and contains most of the histamine in the brain. 80 Hypothalamic mast cell activation can stimulate the HPA axis.
81-83 Histamine is considered a major regulator of hypothalamus 84 and can increase CRH mRNA expression there. 85 Moreover, human mast cells can synthesize and secrete large amounts of CRH 86 as well as IL-1 and IL-6, which are independent activators of the HPA axis. 87 The immunoendocrine responses to stress in chronic skin inflammatory diseases have been reviewed, 12,88 and it was proposed that mast cells constitute the "sensor" of a "brain-skin" connection.
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INFLAMMATORY ARTHRITIS
The presence of mast cells in joints has been known for many years.
17,90-96
Moreover, fluid aspirated from joints of patients with arthrosynovitis contains RANTES and MCP-1, 97 both of which are potent mast cell chemoattractants. Mast cells are required for autoimmune arthritis 98 and inflammatory arthritis, 99 as knee involvement was absent in the joints of W/W v mast cell-deficient mice as compared to their +/+ controls. Inflammatory arthritis was also significantly reduced in CRH knockout mice 99 and in mice treated with the CRH receptor-1 antagonist, Antalarmin. 100 Mast cells in the joints of rheumatoid arthritis (RA) patients express CRH receptors. 101 Moreover, CRH, 101, 102 Ucn, 103, 104 and CRH receptors are increased in the joints of inflammatory and RA patients, the symptoms of whom worsen by stress.
105,106
ASTHMA
Asthma is one of the most common chronic illnesses, affecting roughly 300 million people worldwide. 107, 108 The morbidity and mortality due to asthma continues to increase despite advances in both our scientific knowledge, as well as in hygiene and drugs for this disease. 108 The World Health Organization has estimated that 1 of 250 deaths worldwide is due to asthma. These facts highlight the need for an improved understanding of the cellular and molecular mechanisms that contribute to the pathogenesis of asthma.
Recent reports indicate that stress can exacerbate asthma. [109] [110] [111] [112] [113] [114] One study indicated that maternal stress may be responsible for the subsequent cellular response in childhood asthma. 115 It has been postulated that stress associated with urban living may contribute to poor asthma control. 116 Stress has long been postulated to have a negative impact on asthma, but the mechanisms by which this occurs remain poorly defined. 109, 111, 112, 114, 117, 118 One study showed that adolescents with asthma in a low socioeconomic group, who reported more stressful and acute life events, had more asthma exacerbation and higher serum Th-2 cytokines than those in higher socioeconomic status. 119 The Inner City Asthma Study showed a correlation between community violence and asthma morbidity. 120 Post-traumatic psychological stress following the 9/11 attacks on the World Trade Center correlated with increased symptom severity in subjects with moderate-to-severe asthma and with utilization of urgent care in New York City. 121, 122 In an epidemiological study carried out among 10,667 Finnish first-year university students (18-25 years old), it was shown that an excess of stressful events, such as concomitant severe disease or death of immediate family members or family conflicts, were associated with exacerbation of asthma. 111 Stress associated with final examinations, as compared to mid semester, of college students with mild asthma increased sputum eosinophil counts, as well as eosinophil-derived neurotoxin and IL-5 once the eosinophils were cultured for up to 24 h. 117 It was suggested that a shift in cytokine generation to that of a Th2 type may be the defining parameter. 113 In one longitudinal study of 92 adults with asthma, it was determined that subjects who reported more negative life events and had low levels of social support had more episodes of asthma exacerbation induced by upper respiratory tract infections. 123 A large prospective long-term follow-up community-based cohort study of young adults showed a dose-response relationship between panic and asthma. 124 In fact, one study indicated that maternal stress may be responsible for the cellular response in childhood asthma, 115 while another showed that greater levels of caregiverperceived stress at 2-3 months was associated with increased risk of subsequent repeated wheezing among children during the first 14 months of life. 125 Such findings cannot be easily explained as the HPA axis apparently functions normally in asthmatic adult patients, producing appropriate plasma cortisol increases in response to stress 126 which might be expected to reduce rather than exacerbate asthma symptoms. One publication showed a significantly blunted cortisol response to stress only in asthmatic children, 127 suggesting there may be differences due to age. While no animal model exactly replicates human asthma, the use of animals has provided helpful information about the mechanisms of airway inflammation and hyperreactivity seen in asthma. 128, 129 Chronic exposure to aerosolized ovalbumin has been shown to be a useful murine model of asthma leading to airway inflammation, airway hyperresponsiveness (AHR), 130 as well as microvascular leakage in the airways. [130] [131] [132] Microvascular leakage in the airway wall may also be important for the airway wall remodeling that is found in most asthmatics. 133, 134 More recently, the house dust mite allergen model has been shown to effectively induce chronic airway inflammation and AHR. 133, 135 Stress has been shown to increase AHR 114 and inflammation 114, 136 in response to ovalbumin challenge in murine models of asthma. In one case, exposure to an ultrasonic stressor, coinciding with the first aerosol challenge, significantly increased allergen-induced pulmonary reactivity and bronchial inflammation. Short-term (3 days) stress before allergen challenge decreased the number of inflammatory cells, but increased IL-6, while long-term (7 days) stress evidently increased the number of inflammatory cells but did not alter IL-6 levels. 136 The role of mast cells in asthma is undisputed. [137] [138] [139] Rodent mast cells express bacterial Toll-like receptors (TLRs) 2 and 4. 140, 141 However, the pattern of response may be species-and tissue-specific, making generalizations difficult. TLRs were initially discovered in Drosophila as the receptors responsible for dorso-ventral patterning in the developing embryo; however, soon after they were shown to be important in the development of innate immunity to invading pathogens. 142 Subsequently, human homologues for TLRs were identified beginning with TLR-4, which was shown to bind lipopolysaccharide (LPS). Ten human TLRs have been identified so far. [143] [144] [145] Evidence is building that TLRs play an important role in recognition of ligands associated with bacterial or viral infections, and play a key role in the development of adaptive immune responses, 144 especially in asthma. 146 LPS induced release of TNF-␣ through TLR-4, while peptidoglycan induced histamine release through TLR-2 from rodent mast cells. Fetal rat skin-derived mast cells expressed TLR-3, 7, and 9 and activation by CPG oligodeoxynucleotide induced release of TNF and IL-6, as well as RANTES and MIP, but without degranulation. 147, 148 In another paper, LPS could not induce release of GM-CSF, IL-1, or LTC 4 . 141 However, LPS did induce secretion of TH2 cytokines IL-5, IL-10, and IL-13 and increased their production by FcεRI cross-linking. 149 Elsewhere, it was shown that TLR-2 activation produced IL-4, IL-6, and IL-13, but not IL-1, 150 while LPS produced TNF, IL-1, IL-6, and IL-13, but not IL-4 or IL-5, without degranulation. 150 Activation of these receptors even in human cultured mast cells leads to distinct biological effects: Human mast cells express viral TLR-9, activation of which produced the proinflammatory cytokine IL-6, 151 while they produced IFN in response to double-stranded RNA through TLR-3. 152 These findings may explain how viral infections worsen asthma.
Viral infections have been shown to exacerbate asthma and contribute to as many as 50% of asthma-associated deaths; moreover, more than 80% of childhood asthma exacerbations are associated with viral airway infections. 153 A number of studies have shown that viral infections increase airway hyperresponsiveness and antigen sensitization, 154 as well as recruitment of inflammatory cells. 155 Synoptical virus, metapneumovirus, rhinovirus, adenovirus, 156 as well as influenza and parainfluenza virus have been implicated in the pathogenesis of asthma. [157] [158] [159] In fact, rhinovirus infections during infancy appear to predict childhood wheezing, 160 while respiratory syncytial virus during the first 3 months of life was shown to promote a TH2 response, especially significantly high levels of IL-4. 161 Such early-infancy viral respiratory infections may also induce metalloproteinases, which are involved in airway remodeling in asthma. 162 However, this field is quite confusing because current discussions focus on viral nucleic acid inoculation. 163 
CORONARY INFLAMMATION
Increasing evidence implicates acute psychological stress and cardiac mast cells in coronary artery disease (CAD), especially when it occurs without angina, which appears to involve a sizable portion of myocardial infections (MI). [164] [165] [166] [167] Cardiac mast cells can participate in the development of atherosclerosis, coronary inflammation, and cardiac ischemia. 168 Mast cells are particularly prominent in coronary arteries during spasm 169 and accumulate in the shoulder region of human coronary plaque rupture. [170] [171] [172] The human mast cell proteolytic enzyme chymase is the main cardiac source of converting enzyme that generates the coronary constrictor angiotensin II; 173 the chymase can also induce the removal of cholesterol from HDL particles and uptake by macrophages that become "foam" cells, major components of coronary atheromas. [174] [175] [176] [177] Cardiac mast-cell-derived histamine 178 can constrict the coronary arteries 179 and can sensitize nerve endings; 180 this is particularly important because mast cells are localized close to nerve endings in atherosclerotic coronary arteries. 181 Acute stress induces rat cardiac mast cell activation, an effect blocked by the "mast cell stabilizer" disodium cromoglycate (cromolyn). 182 Acute stress can also induce histamine release from mouse heart, 183 as well as increase serum histamine and IL-6. 183, 184 These effects are dependent on mast cells and are greater in apolipoprotein E (ApoE) knockout mice that develop atherosclerosis. 183, 184 Serum IL-6 elevations in patients with acute CAD were documented to derive primarily from the coronary sinus. 185 Both histamine 186 and IL-6 187 are significant independent factors of CAD morbidity and mortality. There are also reports of anaphylactic CAD that has been termed the "Kounis" syndrome.
188,189
CONCLUSION
Mast cells have emerged as unique immune cells that can be activated by many immune and nonimmune triggers, including acute stress through CRH; it is, therefore, proposed that CRH be renamed SRH (Stress Response Hormone) to reflect its versatile role in stress. Mast cells are critical in the development of inflammatory diseases, especially dermatoses, asthma, arthritis, and CAD. Inhibition of mast cell activation by CRH, 190 therefore, is a novel target for the development of new treatments for inflammatory and autoimmune disorders. Certain dietary supplements have recently been shown to be effective in this regard 191 because they combine the proteoglycan chondroitin sulfate 192 and the flavonoid quercetin, 193 both of which have mast cell inhibitory and anti-inflammatory actions.
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